UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 422

Sortiert nach

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

Alimentary pharmacology & therapeutics, 2011-07, Vol.34 (2), p.125-145

2011

Link zum Volltext

Verfügbarkeit prüfen

The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging

European radiology, 2017-06, Vol.27 (6), p.2570-2582

2017

Link zum Volltext

Verfügbarkeit prüfen

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (3), p.347-357

2018

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease

Gut, 2009-08, Vol.58 (8), p.1113-1120

2009

Link zum Volltext

Verfügbarkeit prüfen

ESGAR consensus statement on the imaging of fistula-in-ano and other causes of anal sepsis

European radiology, 2020-09, Vol.30 (9), p.4734-4740

2020

Link zum Volltext

Verfügbarkeit prüfen

Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

Journal of Crohn's and colitis, 2013-08, Vol.7 (7), p.556-585

2013

Link zum Volltext

Verfügbarkeit prüfen

Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics

Gut, 2015-09, Vol.64 (9), p.1397-1402

2015

Link zum Volltext

Verfügbarkeit prüfen

The development of a magnetic resonance imaging index for fistulising Crohn's disease

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (5), p.516-528

2017

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

Alimentary Pharmacology & Therapeutics (Suppl), 2016-01, Vol.43 (1), p.61-72

2016

Link zum Volltext

Verfügbarkeit prüfen

Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy

Nature reviews. Gastroenterology & hepatology, 2017-11, Vol.14 (11), p.652

2017

Link zum Volltext

Verfügbarkeit prüfen

Modified Side-To-Side Isoperistaltic Strictureplasty over the Ileocaecal Valve: An Alternative to Ileocaecal Resection in Extensive Terminal Ileal Crohn’s Disease

Journal of Crohn's and colitis, 2016-04, Vol.10 (4), p.437-442

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn’s Disease

Journal of Crohn's and colitis, 2016-06, Vol.10 (6), p.663-669

2016

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic insufficiency related to hepatocellular carcinoma treatment: early detection and treatment improves therapeutic adherence

Journal of hepatology, 2017, Vol.66 (1), p.S207-S207

2017

Link zum Volltext

Verfügbarkeit prüfen

P0390 : Baseline bilirubin and not Child-Pugh a or B7 predicts survival of BCLC B patients treated with sorafenib. The clinical approach to the stratification debate

Journal of hepatology, 2015-04, Vol.62, p.S459-S460

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Survival Prediction in Patients under Sorafenib Treatment: Usefulness of Carbonic Anhydrase IX Baseline and Baseline and Evolutive Angiopoyetin 2

Journal of hepatology, 2016, Vol.64 (2), p.S697-S697

2016

Link zum Volltext

Verfügbarkeit prüfen

The Accuracy of the Baseline Peripheral Lymphocyte Value in Predicting Overall Survival in Hepatocellular Carcinoma Patients Treated with Sorafenib Reinforces the Impact of the Immune Response on Tumor Progression

Journal of hepatology, 2016, Vol.64 (2), p.S697-S698

2016

Link zum Volltext

Verfügbarkeit prüfen

Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Journal of hepatology, 2016, Vol.64 (2), p.S319-S319

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2019-08, Vol.157 (2), p.432-439.e1

2019

Link zum Volltext

Verfügbarkeit prüfen

267 DERMATOLOGIC ADVERSE EVENTS WITHIN THE FIRST 60 DAYS OF SORAFENIB TREATMENT ARE ASSOCIATED WITH BETTER OVERALL SURVIVAL (OS) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)

Journal of hepatology, 2013-04, Vol.58, p.S113-S113

2013

Link zum Volltext

Verfügbarkeit prüfen

1026 PROGRESSION RATE PROFILE AND RELATIONSHIP WITH SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB BEYOND FIRST PROGRESSION

Journal of hepatology, 2012-04, Vol.56, p.S401-S401

2012

Link zum Volltext

Verfügbarkeit prüfen

743 APPLICABILITY OF CURATIVE TREATMENTS IN PATIENTS WITH VERY EARLY HEPATOCELLULAR CARCINOMA (BCLC-0). A GROWING NEED IF FOLLOWING PRACTICE GUIDELINES

Journal of hepatology, 2012-04, Vol.56, p.S292-S293

2012

Link zum Volltext

Verfügbarkeit prüfen

647 LIVER TRANSPLANTATION FOR INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA(CHCC-CC)

Journal of hepatology, 2011-03, Vol.54, p.S261-S261

2011

Link zum Volltext

Verfügbarkeit prüfen

704 ABSENCE OF ARTERIAL HYPERVASCULARIZATION AT CEUS DOES NOT RULE OUT HEPATOCELLULAR CARCINOMA IN NODULES ≤2 CM IN A CIRRHOTIC LIVER

Journal of hepatology, 2012-04, Vol.56, p.S278-S278

2012

Link zum Volltext

Verfügbarkeit prüfen

P276 Predictive value of changes in 3D volumetry in perianal fistulas in patients with Crohn’s disease under biologic therapy. A pilot study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i643-i643

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(409)
Mit Volltextzugriff
(359)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(238)
Humans
(220)
Life Sciences & Biomedicine
(216)
Male
(169)
Female
(149)
Biological And Medical Sciences
(141)
Medical Sciences
(140)
Middle Aged
(130)
Adult
(123)
Gastroenterology & Hepatology
(100)
Surgery
(88)
Transplantation
(83)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(78)
Liver Transplantation
(69)
Liver, Biliary Tract, Pancreas, Portal Circulation, Spleen
(57)
Surgery Of The Digestive System
(57)
Immunology
(56)
Aged
(53)
Follow-Up Studies
(37)
Gastroenterology. Liver. Pancreas. Abdomen
(36)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(71)
Hepatology
(42)
Transplantation Proceedings
(34)
Gastroenterology
(27)
Journal Of Crohn's And Colitis
(25)
Transplantation
(20)
American Journal Of Transplantation
(16)
Astronomy And Astrophysics
(14)
Liver Transplantation
(13)
Gastroenterología Y Hepatología
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease

ESGAR consensus statement on the imaging of fistula-in-ano and other causes of anal sepsis

Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics

The development of a magnetic resonance imaging index for fistulising Crohn's disease

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy

Modified Side-To-Side Isoperistaltic Strictureplasty over the Ileocaecal Valve: An Alternative to Ileocaecal Resection in Extensive Terminal Ileal Crohn’s Disease

Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn’s Disease

Pancreatic insufficiency related to hepatocellular carcinoma treatment: early detection and treatment improves therapeutic adherence

P0390 : Baseline bilirubin and not Child-Pugh a or B7 predicts survival of BCLC B patients treated with sorafenib. The clinical approach to the stratification debate

Optimization of Survival Prediction in Patients under Sorafenib Treatment: Usefulness of Carbonic Anhydrase IX Baseline and Baseline and Evolutive Angiopoyetin 2

The Accuracy of the Baseline Peripheral Lymphocyte Value in Predicting Overall Survival in Hepatocellular Carcinoma Patients Treated with Sorafenib Reinforces the Impact of the Immune Response on Tumor Progression

Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

267 DERMATOLOGIC ADVERSE EVENTS WITHIN THE FIRST 60 DAYS OF SORAFENIB TREATMENT ARE ASSOCIATED WITH BETTER OVERALL SURVIVAL (OS) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)

1026 PROGRESSION RATE PROFILE AND RELATIONSHIP WITH SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB BEYOND FIRST PROGRESSION

743 APPLICABILITY OF CURATIVE TREATMENTS IN PATIENTS WITH VERY EARLY HEPATOCELLULAR CARCINOMA (BCLC-0). A GROWING NEED IF FOLLOWING PRACTICE GUIDELINES

647 LIVER TRANSPLANTATION FOR INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) AND COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA(CHCC-CC)

704 ABSENCE OF ARTERIAL HYPERVASCULARIZATION AT CEUS DOES NOT RULE OUT HEPATOCELLULAR CARCINOMA IN NODULES ≤2 CM IN A CIRRHOTIC LIVER

P276 Predictive value of changes in 3D volumetry in perianal fistulas in patients with Crohn’s disease under biologic therapy. A pilot study

Suchergebnisse filtern